Cargando...
Tackling breast cancer chemoresistance with nano-formulated siRNA
Breast cancer is the leading cancer diagnosed in women and the second leading cause of cancer-related deaths in women. Current limitations to standard chemotherapy in the clinic are extensively researched, including problems arising from repeated treatments with the same drugs. The phenomenon that c...
Gardado en:
| Publicado en: | Gene Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5540231/ https://ncbi.nlm.nih.gov/pubmed/27648580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2016.67 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|